Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BARDA funds ZMapp-like Ebola drugs from Medicago, Fraunhofer

This article was originally published in Scrip

Executive Summary

The Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services, has awarded contracts to biotech Medicago and nonprofit research and development firm Fraunhofer to make ZMapp-like Ebola drugs, the head of the agency revealed on 24 February.

Topics

Related Companies

UsernamePublicRestriction

Register

SC027911

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel